[研究报告] 克罗恩病治疗市场在 2023 年的价值为 96.8 亿美元,预计到 2031 年将达到 133.3 亿美元。预计 2023-2031 年的复合年增长率为 4.1%。
市场洞察和分析师观点:
克罗恩病是一种慢性炎症性疾病,主要影响胃肠道。它通常影响小肠末端和大肠起始部分。该疾病的特征是消化道内壁发炎,导致腹痛、腹泻和营养不良等症状。克罗恩病治疗市场规模不断增长,这归因于西方国家(尤其是美国)疾病患病率的上升。此外,公司为保持市场竞争力而采取的战略举措也推动了市场增长。在预测期内,先进医疗设备的使用量大幅增加可能会带来新的克罗恩病治疗市场趋势。
增长动力和挑战:
克罗恩病是一种肠易激综合征,是一种慢性炎症性肠病,目前尚无特效治疗方法。该病的确切病因尚不清楚,但主要是由于肠道对药物、毒素、感染和肠道微生物等环境因素产生不适当的免疫反应,尤其是在遗传易感宿主中。根据美国国家医学图书馆的资料,克罗恩病(CD)在西方发达国家更为常见,尤其是北美和北欧国家以及新西兰。该病在15-30岁和40-60岁人群中发病率最高,在城市地区更为突出。北欧国家和犹太人后裔的发病率较高,为3.2/1,000。然而,最近的研究表明,由于亚洲、非洲和澳大利亚的快速工业化,该地区的发病率也显著增加。因此,克罗恩病在各个地区惊人的患病率促进了克罗恩病治疗市场的发展。
根据美国国立卫生研究院的数据,克罗恩病造成了巨大的经济负担,在欧洲,每位患者每年的直接医疗费用约为 3,500 美元。该病影响每 100,000 人中约 322 人。然而,不同国家的患病率可能有所不同。超过 50% 的克罗恩病患者可能没有得到正式诊断,或者他们可能表现出与其他消化道疾病相同的症状。与男性相比,克罗恩病在女性中更常见,也就是说,女性患者的数量可能是男性的三倍。
参与肠易激综合征药物开发的公司正在采取建设性措施实施宣传计划,旨在通过传播有关症状、诊断和治疗的意识来有效应对这种综合征。2018 年,Allergan PLC 和 Ironwood 合作推出了一个互动数字目的地平台,鼓励患者接受教育并采取行动对抗消化道疾病。因此,肠易激综合征患病率的上升推动了克罗恩病治疗市场的增长。
定制此报告以满足您的需求
您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣
- 获取此报告的关键市场趋势。这个免费样品将包括数据分析,从市场趋势到估计和预测。
报告细分和范围:
克罗恩病治疗市场分析考虑了以下几个部分:药物类型、分销渠道和地理位置。按药物类别,市场细分为抗炎药、免疫系统抑制剂、抗生素、生物制剂、止泻药和止痛药。生物制剂部分在 2023 年占据了最大的市场份额。预计抗炎药部分将在 2023-2031 年期间录得最高复合年增长率。
根据最终用户,市场分为医院药房、临床药房和在线其他药房。医院药房部分在 2023 年占据了克罗恩病治疗市场的最大份额。就地域而言,克罗恩病治疗市场报告的范围包括北美(美国、加拿大和墨西哥)、欧洲(西班牙、英国、德国、法国、意大利和欧洲其他地区)、亚太地区(韩国、中国、日本、印度、澳大利亚和亚太其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋和中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。
区域分析:
北美是全球克罗恩病治疗市场增长的最大贡献者。预计亚太地区将在 2023-2031 年期间创下市场最高复合年增长率。北美市场的发展归因于慢性病发病率的不断上升、技术进步和获得技术先进的医疗产品的渠道、老年人口的激增以及参与新产品和现有产品开发的关键市场参与者的存在。2023 年,美国在北美克罗恩病治疗市场占有最大的份额。
克罗恩病治疗
克罗恩病治疗市场区域洞察
Insight Partners 的分析师已详尽解释了预测期内影响克罗恩病治疗市场的区域趋势和因素。本节还讨论了克罗恩病治疗市场在北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的细分市场和地理位置。
- 获取克罗恩病治疗市场的区域特定数据
克罗恩病治疗市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 96.8亿美元 |
2031 年市场规模 | 133.3亿美元 |
全球复合年增长率(2023 - 2031) | 4.1% |
史料 | 2021-2023 |
预测期 | 2023-2031 |
涵盖的领域 | 按药物类别
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
克罗恩病治疗市场参与者密度:了解其对业务动态的影响
克罗恩病治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。
市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。
在克罗恩病治疗市场运营的主要公司有:
- ABBVIE 公司
- 强生私人有限公司
- 葛兰素史克公司
- 默克公司
- 诺华公司
免责声明:上面列出的公司没有按照任何特定顺序排列。
- 了解克罗恩病治疗市场的主要参与者概况
行业发展和未来机遇:
克罗恩病治疗市场预测是根据各种二手和一手研究结果(如主要公司出版物、协会数据和数据库)估算的。根据公司新闻稿,克罗恩病治疗市场主要参与者的关键发展如下:
- 2023 年,美国食品药品管理局 (FDA) 批准了第一种口服药物 Rinvoq (upadacitinib),用于治疗中度至重度克罗恩病。Rinvoq 旨在治疗无法通过阻断肿瘤坏死因子 (TNF) 的候选药物成功治疗的成年患者。
- 2022 年,FDA 批准 Skyrizi 用于治疗中度至重度活动性克罗恩病的成年人。
- 2021 年,AbbVie Inc. 宣布启动 risankizumab 治疗克罗恩病的 3 期试验。risankizumab 是一种人源化单克隆抗体,可选择性靶向白细胞介素 23 (IL-23) 通路。该试验旨在评估 risankizumab 对中度至重度克罗恩病患者的疗效和安全性。
- 2021年,武田药品工业株式会社宣布启动口服化合物TAK-721治疗克罗恩病的3期试验。TAK-721是趋化因子受体CXCR3的选择性拮抗剂。该试验旨在评估TAK-721对中度至重度克罗恩病患者的疗效和安全性。
竞争格局和重点公司:
Abbvie, Inc.;Johnson and Johnson Private Limited;GlaxoSmithKline Plc;Merck and Co., Inc.;Novartis Ag;Celgene Corporation;Genentech;Pfizer Inc.;Nestle Health Science;以及 Boehringer Ingelheim GmbH 都是克罗恩病治疗市场报告中介绍的知名企业。此外,在研究过程中还研究和分析了其他几家企业,以全面了解市场及其生态系统。这些公司专注于地域扩张和新产品发布,以满足全球消费者日益增长的需求,并通过专业产品组合扩大其产品范围。他们的全球影响力使他们能够服务于庞大的客户群,从而促进市场扩张。
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Explosion-Proof Equipment Market
- Excimer & Femtosecond Ophthalmic Lasers Market
- GMP Cytokines Market
- Vision Guided Robotics Software Market
- Hair Extensions Market
- Procedure Trays Market
- Environmental Consulting Service Market
- Wind Turbine Composites Market
- Rugged Phones Market
- Clinical Trial Supplies Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The increasing burden of irritable bowel syndrome, and the increasing in number of FDA approval and drug development bolster the Crohn’s disease therapeutics market size. However, the high cost of the treatment hinders the Crohn’s disease therapeutics market growth.
Based on geography, the Crohn’s Disease Therapeutics Market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global Crohn’s Disease Therapeutics Market. Asia Pacific is expected to register the highest CAGR in the Crohn’s Disease Therapeutics Market during 2023–2031.
The Crohn’s disease therapeutics market, based on drug class, is segmented into anti-inflammatory drugs, immune system suppressors, antibiotics, biologics, anti-diarrheal, and pain reliever. In 2023, the biologics segment held the largest Crohn’s disease therapeutics market share. The Crohn’s disease therapeutics market, by distribution channel, is segmented into hospital pharmacy, retail pharmacy, online pharmacy. In 2023, the hospital pharmacy segment held the largest Crohn’s disease therapeutics market share and is anticipated to record the highest CAGR during 2023–2031.
The Crohn’s Disease Therapeutics Market majorly consists of the players such Abbvie, Inc.; Johnson and Johnson Private Limited; GlaxoSmithKline Plc; Merck and Co., Inc.; Novartis Ag; Celgene Corporation; Genentech; Pfizer Inc.; Nestle Health Science; and Boehringer Ingelheim Gmbh
Crohn's disease is a chronic inflammatory condition that primarily affects the gastrointestinal tract. It commonly affects the end part of the small intestine and the beginning of the large intestine. The disease is characterized by the inflammation of the digestive tract lining, leading to symptoms such as abdominal pain, diarrhea, and malnutrition. The growing Crohn's disease therapeutics market size is attributed to the increasing prevalence of diseases in Western countries, particularly the US. In addition, strategic initiatives by companies to stay competitive in the market are fueling market growth. A significant increase in the use of medical devices is likely to bring new Crohn's disease therapeutics market trends during the forecast period.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Crohn's Disease Therapeutics Market
- ABBVIE, INC.
- JOHNSON AND JOHNSON PRIVATE LIMITED
- GLAXOSMITHKLINE PLC
- MERCK AND CO., INC.
- NOVARTIS AG
- CELGENE CORPORATION
- GENENTECH
- PFIZER INC.
- NESTLe HEALTH SCIENCE
- BOEHRINGER INGELHEIM GMBH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.